Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

Summary

This is a phase II, multicenter, double-blind, randomized, placebo parallel-controlled clinical trial to evaluate the efficacy and safety of HB0034 in patients with generalized pustular psoriasis (GPP) presenting with an acute flare of moderate to severe intensity.

Timeline

Start

2024-02-29

Primary completion

2025-02-13

Completion

2025-11-30

Drugs

Indications